Laura Denne Selected Research

Carcinoembryonic Antigen

1/2017

Baseline and On-Treatment Markers Determining Prognosis of First-Line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura Denne Research Topics

Disease

1	Neoplasms (Cancer) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

1	Bevacizumab (Avastin)FDA Link 01/2017
1	Carcinoembryonic AntigenIBA 01/2017

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2017